Poland· PL-100422844

Methofill SD

A methotrexate product containing methotrexatum, registered in Poland by Accord Healthcare Polska Sp. z o.o.. The same ATC class is registered in 12 of our 19 countries.

ATC L01BA01

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedMethofill SDATCL01BA01REGISTER NO.PL-100422844PACKS LISTED3CHECKEDSeptember 27, 2026

Where it is registered

Methotrexate is registered in 12 of 19 countries.

Countries holding a registration under ATC L01BA01 (methotrexate), each read from that country’s own register.

  • This record: Poland, from URPL (Poland)
  • 7 of them publish a price we can compare per daily dose

Methotrexate · ATC L01BA01

12 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

URPL (Poland)
Active substance
Methotrexatum
Manufacturer
Accord Healthcare Polska Sp. z o.o.
Country
Poland (PL)
ATC code
L01BA01
ATC class
Methotrexate
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 3

  • gtin
    05909991408442
  • gtin
    05909991408459
  • gtin
    05909991408466

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

949 interactions on record for methotrexate.

Graded by severity as the source publishes them — 107 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Methotrexate · interactions on record

949 records

  • 107 severe
  • 466 moderate
  • 17 minor
  • 309 info

Most severe, free to view

  • OmeprazoleA02BC01severe
  • PantoprazoleA02BC02severe
  • LansoprazoleA02BC03severe
  • RabeprazoleA02BC04severe

50 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Methotrexate in 17 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All methotrexate products

Authorised across Europe · EMA

The same active substance is authorised in 30 EEA countries. Names it is sold under:

  • Austria · Ebetrexat, Methofill
  • Belgium · Basitrin, Emthexate
  • Bulgaria · Ebetrexat, Инжексат
  • Cyprus · Injexate, Methotrexate Accord
  • Czechia · Foxiemo, Injexate
  • Germany · Lantarel, Lantarel Fs
  • Denmark · Ebetrex, Emthexate
  • Estonia · Ebetrex, Metex
  • Spain · Bertanel, Imeth
  • Finland · Ebetrex, Injexate
  • France · Imenor, Imeth
  • United Kingdom (Northern Ireland) · Ebetrex, Injexate
  • Greece · Methobion, Methotrexate Pfizer
  • Croatia · Ebetrexat, Methofill
  • Hungary · Ebetrexat, Methofill
  • Ireland · Methofill, Methotrexate Abcur
  • Iceland · Jylamvo, Methotrexat Ebewe
  • Italy · Afslamet, Immutrex
  • Liechtenstein · Jylamvo, Nordimet
  • Lithuania · Ebetrexat, Metex
  • Luxembourg · Emthexate, Emthexate Teva Pharma
  • Latvia · Ebetrex, Metex
  • Malta · Methotrexate Aspire Pharma (Malta)
  • Netherlands · Basitrin, Ebetrex
  • Norway · Ebetrex, Jylamvo
  • Portugal · Fauldexato, Ledertrexato
  • Romania · Methotrexat Ebewe, Metorthrit
  • Sweden · Ebetrex, Injexate
  • Slovenia · Methofill, Metoject
  • Slovakia · Foxiemo, Injexate

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/ab76fa1e-f9ce-4b69-9d3d-6f25479e020c
GET /v1/drugs/ab76fa1e-f9ce-4b69-9d3d-6f25479e020c?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Roztwór do wstrzykiwań we wstrzykiwaczu",
  "source": "urpl",
  "strength": "10 mg",
  "packaging": "05909991408442 ¦ Rp ¦ 133296\n1 wstrzykiwacz 0,2 ml\n05909991408459 ¦ Rp ¦ 133297\n4 wstrzykiwacze 0,2 ml\n05909991408466 ¦ Rp ¦ 133298\n8 wstrzykiwaczy 0,2 ml",
  "substance": "Methotrexatum 10 mg",
  "common_name": "Methotrexatum",
  "pl_product_id": "100422844",
  "pozwolenie_nr": "243/19",
  "auth_procedure": "IR",
  "authorisation_validity": "2024-07-04"
}

See everything about methotrexate.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.